1162361

Biocon Generics Inc. — FEI 3014086465

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 2, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cranbury, NJ (United States)